Larpparisuth Nuttasith, Cheunsuchon Bunyarit, Chawanasuntorapoj Ratana, Vasuvattakul Somkiat, Vareesangthip Kriengsak
J Med Assoc Thai. 2015 Feb;98(2):212-6.
Warfarin is the most prescribed oral anticoagulant. Adverse renal effect from warfarin therapy are uncommon and Thailand is not acquainted. Warfarin-related nephropathy (WRN) is a newly recognized complication of warfarin treatment, especially in patients with chronic kidney disease. The authors hereby report a 56-year-old man who developed gross hematuria and severe acute kidney injury (AKI) necessitating hemodialysis, following supra-therapeutic INR level. Renal pathology revealed extensive intratubular obstruction with red blood cell casts. From the literature, there were only twelve case reports of WRN, which were confirmed by renal histopatology. Renal survival of this condition was unsatisfactory. However, our patient was dialysis-independent after vitamin K treatment and temporary warfarin discontinuation. To the best of our knowledge, this is the first case report of biopsy-proven WRN in Thailand.
华法林是最常用的口服抗凝剂。华法林治疗引起的肾脏不良反应并不常见,泰国对此并不了解。华法林相关肾病(WRN)是华法林治疗新发现的一种并发症,尤其是在慢性肾脏病患者中。作者在此报告一名56岁男性,在国际标准化比值(INR)高于治疗水平后出现肉眼血尿和严重急性肾损伤(AKI),需要进行血液透析。肾脏病理显示肾小管内广泛阻塞,伴有红细胞管型。据文献记载,经肾脏组织病理学证实的WRN病例报告仅有12例。这种疾病的肾脏存活率并不理想。然而,我们的患者在接受维生素K治疗并暂时停用华法林后不再需要透析。据我们所知,这是泰国首例经活检证实的WRN病例报告。